dMMR/MSI-H-type Rectal Adenocarcinoma
1 clinical trials · Condition
◉ Watch dMMR/MSI-H-type Rectal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT) (NCT07160647) | Sir Run Run Shaw Hospital | 2025-08-20 |
Track dMMR/MSI-H-type Rectal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.